Canton Strategic Holdings CNTN Peer Comparison

NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT
Peer Comparison

300 Comparable Companies

Industry Blockchain Infrastructure

Canton Strategic Holdings, Inc. (CNTN) is the 189th largest of 300 Blockchain Infrastructure companies by market capitalisation, at 493.37 Mn, behind Relmada Therapeutics, Inc. at 498.39 Mn. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 COIN Coinbase Global, Inc. primary T-58 Fintech TG-09 48.45 Bn 0.00 Mn 7.71 39.67 Bn
2 BLSH Bullish primary T-58 Fintech TG-09 4.59 Bn 0.00 Mn 0.02 4.49 Bn
3 CNTN Canton Strategic Holdings, Inc. primary T-58 Fintech TG-09 0.49 Bn 0.00 Mn 326.20 0.49 Bn
4 CYPH Cypherpunk Technologies Inc. primary T-58 Fintech TG-09 0.44 Bn 0.00 Mn — 0.44 Bn
5 CNCK Coincheck Group N.V. primary T-58 Fintech TG-09 0.27 Bn 0.00 Mn 0.08 0.17 Bn
6 WEWA Wewards, Inc. primary T-58 Fintech TG-09 0.21 Bn 0.00 Mn — 0.21 Bn
7 USBC USBC, Inc. primary T-58 Fintech TG-09 0.19 Bn 0.00 Mn — 0.19 Bn
8 TONX TON Strategy Co primary T-58 Fintech TG-09 0.19 Bn 0.00 Mn 8.85 0.19 Bn
9 UTKN Universal Token primary T-58 Fintech TG-09 0.17 Bn 0.00 Mn -120,805.62 0.17 Bn
10 EXOD Exodus Movement, Inc. primary T-58 Fintech TG-09 0.15 Bn 0.00 Mn 1.33 -0.21 Bn
11 STEX Streamex Corp. primary T-58 Fintech TG-09 0.13 Bn 0.00 Mn 747.85 0.11 Bn
12 FRMM FORUM MARKETS Inc primary T-58 Fintech TG-09 0.09 Bn 0.00 Mn 8.41 0.09 Bn
13 BTCS BTCS Inc. primary T-58 Fintech TG-09 0.07 Bn 0.00 Mn 4.16 -0.01 Bn
14 HYPD Hyperion Defi, Inc. primary T-58 Fintech TG-09 0.05 Bn 0.00 Mn 33.14 0.04 Bn
15 STKE SOL Strategies Inc. primary T-58 Fintech TG-09 0.02 Bn 0.00 Mn — 0.02 Bn
16 CBLO C2 Blockchain, Inc. primary T-58 Fintech TG-09 0.01 Bn 0.00 Mn 826.23 0.01 Bn
17 AIXC AIxCrypto Holdings, Inc. primary T-58 Fintech TG-09 0.01 Bn 0.00 Mn — 0.01 Bn
18 GNLN Greenlane Holdings, Inc. primary T-58 Fintech TG-09 0.01 Bn 0.00 Mn 4.39 -0.01 Bn
19 PDC Perpetuals.com Ltd primary T-58 Fintech TG-09 0.01 Bn — — 0.00 Bn
20 LOTT Techlott Inc. primary T-58 Fintech TG-09 0.01 Bn 0.00 Mn — 0.01 Bn
21 IONI I-ON Digital Corp. primary T-58 Fintech TG-09 0.00 Bn 0.00 Mn 8.16 0.00 Bn
22 IPST Ip Strategy Holdings, Inc. primary T-58 Fintech TG-09 0.00 Bn 0.00 Mn 0.17 0.00 Bn
23 DCX Digital Currency X Technology Inc. primary T-58 Fintech TG-09 0.00 Bn 0.00 Mn 1.05 0.00 Bn
24 BKKT-WT Bakkt, Inc. primary T-58 Fintech TG-09 0.00 Bn 0.00 Mn 0.00 -0.05 Bn
25 GROO GROOVY COMPANY, INC. primary T-58 Fintech TG-09 0.00 Bn 0.00 Mn 5.83 0.00 Bn
26 JNJ Johnson & Johnson secondary H-01 Pharmaceuticals and Biotechnology HG-01 663.34 Bn 0.00 Mn 6.77 642.58 Bn
27 ABBV AbbVie Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 453.74 Bn 0.00 Mn 7.05 447.17 Bn
28 MRK Merck & Co., Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 371.80 Bn 0.00 Mn 5.59 364.66 Bn
29 AMGN Amgen Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 236.46 Bn 0.00 Mn 6.21 222.47 Bn
30 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 187.36 Bn 0.00 Mn 6.15 184.18 Bn
31 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 138.47 Bn 0.00 Mn 11.00 130.62 Bn
32 REGN Regeneron Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 85.18 Bn 0.00 Mn 5.48 77.19 Bn
33 ARGX Argenx Se secondary H-02 Pharmaceuticals and Biotechnology HG-01 63.38 Bn 0.00 Mn 12.13 58.19 Bn
34 MRNA Moderna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 58.09 Bn 0.00 Mn 26.07 52.95 Bn
35 SNY Sanofi secondary H-01 Pharmaceuticals and Biotechnology HG-01 54.00 Bn 0.00 Mn 1.01 46.62 Bn
36 TEVA Teva Pharmaceutical Industries Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 42.41 Bn 0.00 Mn 2.45 38.75 Bn
37 ONC BeOne Medicines Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 40.02 Bn 0.00 Mn 6.53 34.92 Bn
38 ALNY Alnylam Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 35.57 Bn 0.00 Mn 7.40 32.27 Bn
39 BIIB Biogen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 32.63 Bn 0.00 Mn 3.25 31.34 Bn
40 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.48 Bn 0.00 Mn 24.15 26.32 Bn
41 INCY Incyte Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 25.44 Bn 0.00 Mn 4.37 20.91 Bn
42 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 25.18 Bn 0.00 Mn 2,305.26 25.18 Bn
43 CRCL Circle Internet Group, Inc. secondary F-22 Capital Markets FG-05 25.16 Bn 0.00 Mn 8.66 23.43 Bn
44 BNTX BioNTech SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 25.06 Bn 0.00 Mn 8.10 11.41 Bn
45 ZBH Zimmer Biomet Holdings, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 18.81 Bn 0.00 Mn 2.21 18.40 Bn
46 ASND Ascendis Pharma A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 16.39 Bn 0.00 Mn 13.42 15.45 Bn
47 MDGL Madrigal Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.79 Bn 0.00 Mn 12.30 14.96 Bn
48 NBIX Neurocrine Biosciences Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.76 Bn 0.00 Mn 4.67 15.37 Bn
49 JAZZ Jazz Pharmaceuticals plc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.60 Bn 0.00 Mn 3.39 13.98 Bn
50 EXEL Exelixis, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 14.81 Bn 0.00 Mn 6.08 13.97 Bn
51 BBIO BridgeBio Pharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 14.65 Bn 0.00 Mn 20.55 13.93 Bn
52 SMMT Summit Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 13.67 Bn — — 12.98 Bn
53 HALO Halozyme Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.92 Bn 0.00 Mn 7.77 12.69 Bn
54 BMRN Biomarin Pharmaceutical Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.88 Bn 0.00 Mn 3.78 12.01 Bn
55 ARWR Arrowhead Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.40 Bn 0.00 Mn 18.52 10.80 Bn
56 AXSM Axsome Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 10.75 Bn 0.00 Mn 13.84 10.43 Bn
57 GMED Globus Medical Inc secondary H-06 Medical Devices and Diagnostics HG-02 10.59 Bn 0.00 Mn 3.37 9.99 Bn
58 GPCR Structure Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 10.32 Bn 0.00 Mn — 10.32 Bn
59 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.28 Bn 0.00 Mn — 9.52 Bn
60 APGE Apogee Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn 0.00 Mn — 9.20 Bn
61 RDY Dr Reddys Laboratories Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 9.95 Bn 0.00 Mn 2.72 9.78 Bn
62 PTGX Protagonist Therapeutics, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.61 Bn 0.00 Mn 34.07 9.61 Bn
63 IONS Ionis Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.60 Bn 0.00 Mn 10.98 7.55 Bn
64 PCVX Vaxcyte, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.83 Bn 0.00 Mn — 8.83 Bn
65 IBRX ImmunityBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.51 Bn 0.00 Mn 51.33 8.15 Bn
66 IMVT Immunovant, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.07 Bn 0.00 Mn — 8.07 Bn
67 ABVX Abivax S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.99 Bn 0.00 Mn — 7.99 Bn
68 TGTX Tg Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.97 Bn 0.00 Mn 9.97 7.29 Bn
69 SYRE Spyre Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.53 Bn 0.00 Mn — 7.53 Bn
70 SRRK Scholar Rock Holding Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.24 Bn 0.00 Mn — 7.24 Bn
71 RYTM Rhythm Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.02 Bn 0.00 Mn 29.27 6.69 Bn
72 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.64 Bn 0.00 Mn 4,772.92 6.64 Bn
73 CGON CG Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.60 Bn 0.00 Mn 1,060.37 6.60 Bn
74 MIRM Mirum Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.40 Bn 0.00 Mn 10.35 5.96 Bn
75 KNSA Kiniksa Pharmaceuticals International, plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.05 Bn 0.00 Mn 7.20 5.53 Bn
76 XENE Xenon Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.96 Bn 0.00 Mn — 5.96 Bn
77 COGT Cogent Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.94 Bn 0.00 Mn — 5.94 Bn
78 DBVT DBV Technologies S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.88 Bn 0.00 Mn 1,170.87 5.70 Bn
79 ORKA Oruka Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.85 Bn — — 4.12 Bn
80 PTCT Ptc Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.78 Bn 0.00 Mn 5.73 3.55 Bn
81 LGND Ligand Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.76 Bn 0.00 Mn 19.84 4.41 Bn
82 GRFS Grifols SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.31 Bn 0.00 Mn 0.32 4.15 Bn
83 CELC Celcuity Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.25 Bn 0.00 Mn — 5.25 Bn
84 GLXY Galaxy Digital Inc. secondary F-22 Capital Markets FG-05 5.08 Bn 0.00 Mn 0.09 3.53 Bn
85 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.04 Bn 0.00 Mn — 5.04 Bn
86 RADX Radiopharm Theranostics Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.33 Bn 0.00 Mn 20,980.03 4.33 Bn
87 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.18 Bn 0.00 Mn 1,161.10 4.18 Bn
88 DNTH Dianthus Therapeutics, Inc. /DE/ secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.09 Bn — — 3.69 Bn
89 VKTX Viking Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.06 Bn 0.00 Mn — 4.06 Bn
90 TLX Telix Pharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.03 Bn — — 3.74 Bn
91 DYN Dyne Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.02 Bn 0.00 Mn — 4.02 Bn
92 IOVA Iovance Biotherapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 3.95 Bn 0.00 Mn 12.17 3.66 Bn
93 RLAY Relay Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.87 Bn 0.00 Mn 373.95 3.87 Bn
94 AMLX Amylyx Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.79 Bn 0.00 Mn — 3.79 Bn
95 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.74 Bn 0.00 Mn 31.96 3.04 Bn
96 IDYA IDEAYA Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.68 Bn 0.00 Mn 15.73 2.85 Bn
97 ABCL AbCellera Biologics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.49 Bn 0.00 Mn 52.71 3.49 Bn
98 TNGX Tango Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.37 Bn 0.00 Mn 62.56 2.35 Bn
99 ARQT Arcutis Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.12 Bn 0.00 Mn 6.73 2.88 Bn
100 CLDX Celldex Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.10 Bn 0.00 Mn 19,590.55 3.10 Bn
101 IRON Disc Medicine, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.06 Bn 0.00 Mn — 3.06 Bn
102 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.03 Bn 0.00 Mn 593.06 2.51 Bn
103 MBX MBX Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.97 Bn 0.00 Mn — 2.97 Bn
104 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.94 Bn 0.00 Mn 6.53 2.23 Bn
105 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.90 Bn 0.00 Mn 78.89 2.46 Bn
106 TAK Takeda Pharmaceutical Co Ltd secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.64 Bn 0.00 Mn 0.06 -3.16 Bn
107 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.62 Bn 0.00 Mn — 2.62 Bn
108 VERA Vera Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.58 Bn 0.00 Mn — 2.58 Bn
109 AXGN Axogen, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 2.57 Bn 0.00 Mn 10.22 2.46 Bn
110 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.54 Bn 0.00 Mn 4.75 2.19 Bn
111 SUPN Supernus Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.54 Bn 0.00 Mn 3.22 2.17 Bn
112 NKTR Nektar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.45 Bn 0.00 Mn 44.90 1.77 Bn
113 HRMY Harmony Biosciences Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.45 Bn 0.00 Mn 2.55 1.64 Bn
114 HCM HUTCHMED (China) Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.43 Bn 0.00 Mn 3.41 2.43 Bn
115 VRDN Viridian Therapeutics, Inc.\DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.42 Bn 0.00 Mn 33.96 2.42 Bn
116 OCUL Ocular Therapeutix, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.40 Bn 0.00 Mn 46.07 2.40 Bn
117 NUVB Nuvation Bio Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.38 Bn 0.00 Mn 14.01 2.38 Bn
118 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.37 Bn 0.00 Mn — 2.10 Bn
119 SRPT Sarepta Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 2.36 Bn 0.00 Mn 1.20 1.57 Bn
120 XTLB Xtl Biopharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.27 Bn 0.00 Mn — 2.27 Bn
121 URGN UroGen Pharma Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.23 Bn 0.00 Mn 11.79 2.12 Bn
122 KOD Kodiak Sciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.21 Bn 0.00 Mn — 2.21 Bn
123 ADMA Adma Biologics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.19 Bn 0.00 Mn 4.28 2.06 Bn
124 GMAB Genmab A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.17 Bn 0.00 Mn 0.34 0.67 Bn
125 RAPP Rapport Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.17 Bn 0.00 Mn 108.62 2.17 Bn
126 ZYME Zymeworks Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.13 Bn 0.00 Mn 57.49 1.86 Bn
127 AUPH Aurinia Pharmaceuticals Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.10 Bn 0.00 Mn 6.74 1.66 Bn
128 PHVS Pharvaris N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.10 Bn 0.00 Mn — 1.73 Bn
129 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.09 Bn 0.00 Mn 2,085.86 2.09 Bn
130 XNCR Xencor Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.02 Bn 0.00 Mn 19.28 1.65 Bn
131 AGIO Agios Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.97 Bn 0.00 Mn 20.05 1.97 Bn
132 STOK Stoke Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.96 Bn 0.00 Mn 71.02 1.67 Bn
133 TYRA Tyra Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.94 Bn 0.00 Mn — 1.94 Bn
134 RXRX Recursion Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.93 Bn 0.00 Mn 35.26 1.38 Bn
135 VIR Vir Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.92 Bn 0.00 Mn 6.32 1.92 Bn
136 INBX Inhibrx Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.91 Bn 0.00 Mn 1,465.41 1.91 Bn
137 LKFT Lakefront Biotherapeutics NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.88 Bn 0.00 Mn 1.63 1.88 Bn
138 IMCR Immunocore Holdings plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.85 Bn 0.00 Mn 4.28 0.97 Bn
139 DMRA Damora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.83 Bn 0.00 Mn — 1.29 Bn
140 SNDX Syndax Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.83 Bn 0.00 Mn 7.25 1.28 Bn
141 CMPS COMPASS Pathways plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.79 Bn 0.00 Mn — 1.79 Bn
142 SCNI Scinai Immunotherapeutics Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.77 Bn 0.00 Mn 1,025.82 1.76 Bn
143 GHRS GH Research PLC secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.72 Bn 0.00 Mn — 1.36 Bn
144 NVAX Novavax Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn 0.00 Mn 4.06 0.96 Bn
145 SEPN Septerna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.66 Bn 0.00 Mn 16.77 1.66 Bn
146 ANAB Anaptysbio, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.62 Bn 0.00 Mn 8.14 1.34 Bn
147 ATAI AtaiBeckley Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.61 Bn 0.00 Mn 530.56 1.61 Bn
148 FBRX Forte Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn 0.00 Mn — 1.23 Bn
149 BCAX Bicara Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn 0.00 Mn — 1.57 Bn
150 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn 0.00 Mn 20.12 1.29 Bn
151 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.56 Bn 0.00 Mn 2.18 1.27 Bn
152 MAZE Maze Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.55 Bn 0.00 Mn 77.46 1.55 Bn
153 ANRO Alto Neuroscience, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.52 Bn 0.00 Mn — 1.52 Bn
154 SDGR Schrodinger, Inc. secondary T-27 Vertical Software TG-05 1.50 Bn 0.00 Mn 5.79 1.09 Bn
155 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.48 Bn 0.00 Mn — 1.48 Bn
156 REPL Replimune Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.46 Bn 0.00 Mn — 1.46 Bn
157 ALMS Alumis Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn 0.00 Mn 170.77 0.92 Bn
158 GLUE Monte Rosa Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.40 Bn 0.00 Mn 48.89 0.77 Bn
159 ABSI Absci Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.39 Bn 0.00 Mn 889.25 1.19 Bn
160 ORIC Oric Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn 0.00 Mn — 1.38 Bn
161 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn 0.00 Mn 35.80 1.38 Bn
162 CGEM Cullinan Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn 0.00 Mn — 1.37 Bn
163 SVRA Savara Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn 0.00 Mn — 1.36 Bn
164 VOR Vor Biopharma Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn 0.00 Mn — 1.36 Bn
165 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.33 Bn 0.00 Mn — 1.12 Bn
166 JANX Janux Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.27 Bn 0.00 Mn 52.84 1.27 Bn
167 MNKD Mannkind Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn 0.00 Mn 3.21 1.15 Bn
168 JBIO Jade Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.21 Bn 0.00 Mn — 1.21 Bn
169 CLYM Climb Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn 0.00 Mn — 1.18 Bn
170 IMTX Immatics N.V. secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.17 Bn 0.00 Mn 24.04 0.71 Bn
171 MLTX MoonLake Immunotherapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.11 Bn 0.00 Mn — 0.57 Bn
172 OKYO OKYO Pharma Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.05 Bn 0.00 Mn — 1.05 Bn
173 GERN Geron Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.05 Bn 0.00 Mn 4.32 0.75 Bn
174 ABUS Arbutus Biopharma Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 0.00 Mn 5.61 0.93 Bn
175 MNPR Monopar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 0.00 Mn — 0.95 Bn
176 WVE Wave Life Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.99 Bn 0.00 Mn 15.21 0.63 Bn
177 ANNX Annexon, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.98 Bn 0.00 Mn — 0.98 Bn
178 ARDX Ardelyx, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.93 Bn 0.00 Mn 2.07 0.65 Bn
179 RIGL Rigel Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.90 Bn 0.00 Mn 3.26 0.81 Bn
180 STTK Shattuck Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.89 Bn 0.00 Mn 885.09 0.89 Bn
181 TBPH Theravance Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 0.00 Mn 8.46 0.50 Bn
182 ACRS Aclaris Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 0.00 Mn 107.41 0.88 Bn
183 AVTX Avalo Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.84 Bn 0.00 Mn — 0.84 Bn
184 VSTM Verastem, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.81 Bn 0.00 Mn 9.31 0.68 Bn
185 CTMX CytomX Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.81 Bn 0.00 Mn 44.44 0.48 Bn
186 PHAR Pharming Group N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn 0.00 Mn 2.39 0.64 Bn
187 ZURA Zura Bio Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn 0.00 Mn — 0.79 Bn
188 ZVRA Zevra Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.73 Bn 0.00 Mn 5.39 0.51 Bn
189 BBOT BridgeBio Oncology Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.72 Bn 0.00 Mn — 0.50 Bn
190 AURA Aura Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.72 Bn 0.00 Mn — 0.65 Bn
191 IRWD Ironwood Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.70 Bn 0.00 Mn 1.80 0.62 Bn
192 VBNK VersaBank secondary F-02 Banking FG-01 0.70 Bn 0.00 Mn 6.49 0.70 Bn
193 SLN Silence Therapeutics plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.69 Bn 0.00 Mn 1,122.93 0.62 Bn
194 ASMB Assembly Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.69 Bn 0.00 Mn 9.21 0.37 Bn
195 CRMD CorMedix Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.66 Bn 0.00 Mn 1.77 0.41 Bn
196 ALT Altimmune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn 0.00 Mn — 0.64 Bn
197 CBIO Crescent Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn 0.00 Mn 612.11 0.46 Bn
198 OCS Oculis Holding AG secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -0.36 Mn — 0.35 Bn
199 CTNM Contineum Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn 0.00 Mn — 0.63 Bn
200 ARVN Arvinas, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn 0.00 Mn 1.93 0.04 Bn
201 TECX Tectonic Therapeutic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn 0.00 Mn — 0.59 Bn
202 SGMT Sagimet Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn 0.00 Mn — 0.58 Bn
203 VALN Valneva SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn 551.06 Mn 3.47 0.44 Bn
204 FLGT Fulgent Genetics, Inc. secondary H-17 Healthcare Providers HG-04 0.56 Bn 0.00 Mn 2.30 0.30 Bn
205 OABI OmniAb, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.55 Bn 0.00 Mn 14.37 0.50 Bn
206 OVID Ovid Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.55 Bn 0.00 Mn 348.63 0.43 Bn
207 IMUX Immunic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.55 Bn 0.00 Mn — 0.55 Bn
208 PRLD Prelude Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.54 Bn 0.00 Mn 24.04 0.26 Bn
209 PRTA Prothena Corp Public Ltd Co secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn 0.00 Mn 9.41 0.22 Bn
210 ANL Adlai Nortye Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn 0.00 Mn 78.36 0.27 Bn
211 RLMD Relmada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn 0.00 Mn — 0.50 Bn
212 CCCC C4 Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 0.00 Mn 14.06 0.24 Bn
213 KMDA Kamada Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 0.00 Mn 2.56 0.42 Bn
214 PBYI Puma Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 0.00 Mn 2.11 0.39 Bn
215 RZLT Rezolute, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.48 Bn 0.00 Mn — 0.48 Bn
216 NEUP Neuphoria Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 0.00 Mn — 0.45 Bn
217 AVIR Atea Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 0.00 Mn — 0.47 Bn
218 OCGN Ocugen, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 0.00 Mn 100.20 0.36 Bn
219 ARCT Arcturus Therapeutics Holdings Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn 0.00 Mn 15.31 0.26 Bn
220 DRUG Bright Minds Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn 0.00 Mn — 0.23 Bn
221 OWLS Obook Holdings Inc. secondary T-54 Fintech TG-09 0.45 Bn 0.00 Mn 63.54 0.43 Bn
222 CMPX Compass Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn 0.00 Mn — 0.45 Bn
223 EVMN Evommune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn 0.00 Mn 44.52 0.24 Bn
224 BIOA BioAge Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.43 Bn 0.00 Mn 41.79 0.43 Bn
225 BTQ BTQ Technologies Corp. secondary T-42 Infrastructure Software TG-06 0.41 Bn 0.00 Mn 1,019.17 0.41 Bn
226 ENTA Enanta Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn 0.00 Mn 6.27 0.22 Bn
227 EYPT EyePoint, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn 0.00 Mn 142.89 0.22 Bn
228 LRMR Larimar Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn 0.00 Mn — 0.24 Bn
229 OFIX Orthofix Medical Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.38 Bn 0.00 Mn 0.46 0.28 Bn
230 CATX Perspective Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn 0.00 Mn — 0.38 Bn
231 WHWK Whitehawk Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn 0.00 Mn — 0.38 Bn
232 FHTX Foghorn Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn 0.00 Mn 9.47 0.28 Bn
233 ELDN Eledon Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn 0.00 Mn — 0.34 Bn
234 SCTH Securetech Innovations, Inc. secondary T-61 Robotics and Automation TG-10 0.34 Bn — — 0.34 Bn
235 AGEN Agenus Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn 0.00 Mn 2.58 0.34 Bn
236 STRO Sutro Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn 0.00 Mn 3.72 0.17 Bn
237 EPRX Eupraxia Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn 0.00 Mn — 0.33 Bn
238 UPB Upstream Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn 0.00 Mn 103.85 0.33 Bn
239 CLLS Cellectis S.A. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.32 Bn 0.00 Mn 5.47 0.16 Bn
240 GALT Galectin Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn — 0.30 Bn
241 BCYC Bicycle Therapeutics Plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn 4.90 0.30 Bn
242 TRDA Entrada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn 63.39 0.30 Bn
243 SABS SAB Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn — 0.30 Bn
244 TLSI TriSalus Life Sciences, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.29 Bn 0.00 Mn 6.48 0.25 Bn
245 ACIU AC Immune SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 0.00 Mn 12.87 0.29 Bn
246 MGNX Macrogenics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn 0.00 Mn 1.70 0.17 Bn
247 CELG-RI Bristol Myers Squibb Co secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.28 Bn 0.00 Mn 0.01 -10.79 Bn
248 ALXO Alx Oncology Holdings Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn 0.00 Mn — 0.27 Bn
249 ALEC Alector, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn 0.00 Mn 19.66 0.10 Bn
250 AVXL Anavex Life Sciences Corp. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn 0.00 Mn — 0.15 Bn
251 IVVD Invivyd, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn 4.70 0.10 Bn
252 SRZN Surrozen, Inc./DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn 22.88 0.26 Bn
253 ANTX AN2 Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn — 0.26 Bn
254 AKBA Akebia Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn 1.20 0.11 Bn
255 CAMP Camp4 Therapeutics Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn 61.69 0.26 Bn
256 CYDY CytoDyn Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn — 0.26 Bn
257 FIXX Q32 Bio Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn — 0.15 Bn
258 PYXS Pyxis Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 0.00 Mn 18.03 0.22 Bn
259 EQ Equillium, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 0.00 Mn — 0.25 Bn
260 NMRA Neumora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn 0.00 Mn — 0.24 Bn
261 CGEN Compugen Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn 0.00 Mn 3.28 0.16 Bn
262 TARA Protara Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.24 Bn 0.00 Mn — 0.24 Bn
263 YDES YD Bio Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn 0.00 Mn 287.04 0.23 Bn
264 GLSI Greenwich LifeSciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.00 Mn — 0.23 Bn
265 BGIN BGIN BLOCKCHAIN Ltd secondary T-01 Semiconductors TG-01 0.23 Bn 0.00 Mn 3.41 0.20 Bn
266 ABOS Acumen Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.00 Mn — 0.23 Bn
267 FTH Faeth Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.00 Mn — 0.23 Bn
268 KROS Keros Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 6.82 -0.03 Bn
269 CHRS Coherus Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 4.35 0.12 Bn
270 ORGO Organogenesis Holdings Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.22 Bn 0.00 Mn 0.48 0.17 Bn
271 TNXP Tonix Pharmaceuticals Holding Corp. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 7.52 0.22 Bn
272 PRQR ProQR Therapeutics N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 10.17 0.08 Bn
273 FUFU Bitfufu Inc. secondary T-59 Fintech TG-09 0.22 Bn 0.00 Mn 0.55 0.20 Bn
274 PEPG PepGen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn — 0.22 Bn
275 KRRO Korro Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 90.64 0.10 Bn
276 PLX Protalix BioTherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn 2.64 0.17 Bn
277 ARMP Armata Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn — 0.19 Bn
278 ADAG Adagene Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn 32.66 0.21 Bn
279 VYGR Voyager Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn 6.11 0.09 Bn
280 ADCT ADC Therapeutics SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn 2.77 -0.01 Bn
281 ACOG Alpha Cognition Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn 15.36 0.16 Bn
282 ORMP Oramed Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn — 0.21 Bn
283 NBP NovaBridge Biosciences secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn 0.00 Mn — 0.20 Bn
284 RDHL RedHill Biopharma Ltd. secondary H-04 Pharmaceuticals and Biotechnology HG-01 0.19 Bn 0.00 Mn 36.65 0.19 Bn
285 IPHA Innate Pharma SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn 0.00 Mn 60.95 0.19 Bn
286 QNCX Quince Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn 0.00 Mn — 0.18 Bn
287 OKUR OnKure Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn 0.00 Mn — 0.00 Bn
288 XLO Xilio Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn 0.00 Mn 2.75 0.04 Bn
289 CUE Cue Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn 0.00 Mn 7.74 0.16 Bn
290 NGEN Nervgen Pharma Corp. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn 0.00 Mn — 0.17 Bn
291 MIST Milestone Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn — — -0.01 Bn
292 RANI Rani Therapeutics Holdings, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn 0.00 Mn 33.54 0.16 Bn
293 MOLN Molecular Partners Ag secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn 0.00 Mn 28.43 0.16 Bn
294 DFDV DeFi Development Corp. secondary T-29 Vertical Software TG-05 0.16 Bn 0.00 Mn 3.66 0.15 Bn
295 DVLT Datavault AI Inc. secondary T-36 Infrastructure Software TG-06 0.15 Bn 0.00 Mn 3.24 0.15 Bn
296 ENTX Entera Bio Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn 0.00 Mn — 0.14 Bn
297 MDWD MediWound Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn 0.00 Mn 12.79 0.12 Bn
298 IFRX InflaRx N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn 0.00 Mn 1,890.67 -0.04 Bn
299 SPRB Spruce Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn — 0.14 Bn
300 UNCY Unicycive Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn — 0.14 Bn